ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.36
0.17%
US Tech 100
20,772.80
-0.98%
S&P 500
6,037.88
0.72%
US Dollar vs CAD
1.42847
-0.35%
Bitcoin
97,621.53
-0.24%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. MannKind Corporation (MNKD)

  7. MannKind Corporation (MNKD) News

MNKD

MannKind (MNKD)

MannKind Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MNKD
DateTimeSourceHeadlineSymbolCompany
01/29/20258:00PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
01/06/20254:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNKDMannKind Corporation
01/06/20253:30PMGlobeNewswire Inc.MannKind Expands Executive Leadership TeamNASDAQ:MNKDMannKind Corporation
12/18/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNKDMannKind Corporation
12/18/20246:00AMGlobeNewswire Inc.MannKind Corporation Announces Exchange of Convertible Notes for Stock and CashNASDAQ:MNKDMannKind Corporation
12/16/20245:05AMGlobeNewswire Inc.MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®)NASDAQ:MNKDMannKind Corporation
12/11/20245:00AMGlobeNewswire Inc.CDSCO Approves Afrezza® (insulin human) Inhalation Powder in IndiaNASDAQ:MNKDMannKind Corporation
11/25/20248:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
11/22/20243:08PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
11/19/20248:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
11/15/20243:01PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
11/08/20248:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
11/07/20243:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MNKDMannKind Corporation
11/07/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNKDMannKind Corporation
11/07/20243:02PMGlobeNewswire Inc.MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business UpdateNASDAQ:MNKDMannKind Corporation
11/06/20243:04PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
11/05/20243:15PMGlobeNewswire Inc.MannKind to Present at 2024 UBS Healthcare ConferenceNASDAQ:MNKDMannKind Corporation
11/04/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
11/04/20245:05AMGlobeNewswire Inc.MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic DiseasesNASDAQ:MNKDMannKind Corporation
10/31/20243:05PMGlobeNewswire Inc.MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024NASDAQ:MNKDMannKind Corporation
09/30/20245:00AMGlobeNewswire Inc.More Adults With Type 1 Diabetes Achieved A1C Goal (<7%) After Switching From Multiple Daily Insulin Injections or Automated Pumps to Inhaled Insulin (Afrezza®)NASDAQ:MNKDMannKind Corporation
09/18/20245:15AMGlobeNewswire Inc.MannKind Announces Clearance from PMDA to Initiate Phase 3 Clinical Trial (ICoN-1) in Japan Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung DiseaseNASDAQ:MNKDMannKind Corporation
09/10/20243:30PMGlobeNewswire Inc.MannKind to Present at 2024 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:MNKDMannKind Corporation
09/04/20248:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
09/03/20243:25PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
08/30/20243:35PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
08/29/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
08/29/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
08/29/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
08/29/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
 Showing the most relevant articles for your search:NASDAQ:MNKD

Your Recent History

USOTC
RDGL
Vivos (QB)
USOTC
CLHI
CLST (PK)
USOTC
PHIL
PHI (PK)
USOTC
AXXA
Exxe (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
ASII
Accredited Solutions (PK)
USOTC
TGLO
TheGlobe com (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
USOTC
INKW
Greene Concepts (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
MGON
Megola (PK)
NYSE
IONQ
IonQ
USOTC
BMXI
Brookmount Explorations (PK)
NASDAQ
COOP
Mr Cooper
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads